131 related articles for article (PubMed ID: 29181691)
1. Irreversible phenotypic perturbation and functional impairment of B cells during HIV-1 infection.
Yan J; Zhang S; Sun J; Xu J; Zhang X
Front Med; 2017 Dec; 11(4):536-547. PubMed ID: 29181691
[TBL] [Abstract][Full Text] [Related]
2. Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy.
Cagigi A; Nilsson A; Pensieroso S; Chiodi F
Lancet Infect Dis; 2010 Jul; 10(7):499-503. PubMed ID: 20610332
[TBL] [Abstract][Full Text] [Related]
3. Concerted effect of lymphopenia, viraemia and T-cell activation on Fas expression of peripheral B cells in HIV-1-infected patients.
Rethi B; Sammicheli S; Amu S; Pensieroso S; Hejdeman B; Schepis D; Thang PH; Chiodi F
AIDS; 2013 Jan; 27(2):155-62. PubMed ID: 23238551
[TBL] [Abstract][Full Text] [Related]
4. Impact of Aging, Cytomegalovirus Infection, and Long-Term Treatment for Human Immunodeficiency Virus on CD8
Veel E; Westera L; van Gent R; Bont L; Otto S; Ruijsink B; Rabouw HH; Mudrikova T; Wensing A; Hoepelman AIM; Borghans JAM; Tesselaar K
Front Immunol; 2018; 9():572. PubMed ID: 29619031
[TBL] [Abstract][Full Text] [Related]
5. Beneficial Effects of cART Initiated during Primary and Chronic HIV-1 Infection on Immunoglobulin-Expression of Memory B-Cell Subsets.
Pogliaghi M; Ripa M; Pensieroso S; Tolazzi M; Chiappetta S; Nozza S; Lazzarin A; Tambussi G; Scarlatti G
PLoS One; 2015; 10(10):e0140435. PubMed ID: 26474181
[TBL] [Abstract][Full Text] [Related]
6. Impact of HIV infection and highly active antiretroviral therapy (HAART) on B cell subpopulations in children.
Singh R; Mukherjee A; Singla M; Vajpayee M; Negi N; Kabra SK; Lodha R; Das BK
J Med Virol; 2018 Jul; 90(7):1222-1231. PubMed ID: 29575050
[TBL] [Abstract][Full Text] [Related]
7. Altered Memory Circulating T Follicular Helper-B Cell Interaction in Early Acute HIV Infection.
Muir R; Metcalf T; Tardif V; Takata H; Phanuphak N; Kroon E; Colby DJ; Trichavaroj R; Valcour V; Robb ML; Michael NL; Ananworanich J; Trautmann L; Haddad EK;
PLoS Pathog; 2016 Jul; 12(7):e1005777. PubMed ID: 27463374
[TBL] [Abstract][Full Text] [Related]
8. Persistent subclinical immune defects in HIV-1-infected children treated with antiretroviral therapy.
van den Heuvel D; Driessen GJ; Berkowska MA; van der Burg M; Langerak AW; Zhao D; Charif H; Hartwig NG; van Rossum AM; Fraaij PL; van Dongen JJ; van Zelm MC
AIDS; 2015 Sep; 29(14):1745-56. PubMed ID: 26372381
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated memory B cell perturbations.
Hu Z; Luo Z; Wan Z; Wu H; Li W; Zhang T; Jiang W
Vaccine; 2015 May; 33(22):2524-9. PubMed ID: 25887082
[TBL] [Abstract][Full Text] [Related]
10. Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV.
Bussmann BM; Reiche S; Bieniek B; Krznaric I; Ackermann F; Jassoy C
Virology; 2010 Feb; 397(1):7-13. PubMed ID: 19962720
[TBL] [Abstract][Full Text] [Related]
11. Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impairment of JAK-STAT signaling pathway.
Liu MQ; Zhao M; Kong WH; Tang L; Wang F; Zhu ZR; Wang X; Qiu HY; Zhou DJ; Wang X; Ho WZ; Zhou W
Oncotarget; 2017 Apr; 8(14):22524-22533. PubMed ID: 28186978
[TBL] [Abstract][Full Text] [Related]
12. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
[TBL] [Abstract][Full Text] [Related]
13. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
Tsai A; Irrinki A; Kaur J; Cihlar T; Kukolj G; Sloan DD; Murry JP
J Virol; 2017 Apr; 91(8):. PubMed ID: 28179531
[TBL] [Abstract][Full Text] [Related]
14. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
[TBL] [Abstract][Full Text] [Related]
15. Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
Chaix ML; Seng R; Frange P; Tran L; Avettand-Fenoël V; Ghosn J; Reynes J; Yazdanpanah Y; Raffi F; Goujard C; Rouzioux C; Meyer L;
Clin Infect Dis; 2013 Mar; 56(6):880-7. PubMed ID: 23223603
[TBL] [Abstract][Full Text] [Related]
16. Early Antiretroviral Therapy Preserves Functional Follicular Helper T and HIV-Specific B Cells in the Gut Mucosa of HIV-1-Infected Individuals.
Planchais C; Hocqueloux L; Ibanez C; Gallien S; Copie C; Surenaud M; Kök A; Lorin V; Fusaro M; Delfau-Larue MH; Lefrou L; Prazuck T; Lévy M; Seddiki N; Lelièvre JD; Mouquet H; Lévy Y; Hüe S
J Immunol; 2018 May; 200(10):3519-3529. PubMed ID: 29632141
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic Correlates of Simian Immunodeficiency Virus-Associated B Cell Dysfunction.
Brocca-Cofano E; Kuhrt D; Siewe B; Xu C; Haret-Richter GS; Craigo J; Labranche C; Montefiori DC; Landay A; Apetrei C; Pandrea I
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931679
[TBL] [Abstract][Full Text] [Related]
18. The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients.
Redgrave BE; Stone SF; French MA; Krueger R; James IR; Price P
HIV Med; 2005 Sep; 6(5):307-12. PubMed ID: 16156877
[TBL] [Abstract][Full Text] [Related]
19. Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease.
Moir S; Malaspina A; Ho J; Wang W; Dipoto AC; O'Shea MA; Roby G; Mican JM; Kottilil S; Chun TW; Proschan MA; Fauci AS
J Infect Dis; 2008 Feb; 197(4):572-9. PubMed ID: 18240953
[TBL] [Abstract][Full Text] [Related]
20. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals.
Martinson JA; Tenorio AR; Montoya CJ; Al-Harthi L; Gichinga CN; Krieg AM; Baum LL; Landay AL
Immunology; 2007 Apr; 120(4):526-35. PubMed ID: 17343615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
